Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2025-02-12 00:00:00 ET · period of report 2025-02-10 · accession 0001415889-25-003824 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-12 | 2025-02-12 | TVTX | ROTE WILLIAM E. | SVP, R, D | S - Sale+OE | $23.53 | -5,200 | 98.5K | -5% | -$122.4K |
| D | 2025-02-12 | 2025-02-10 | TVTX | ROTE WILLIAM E. | SVP, R, D | M - OptEx | — | +8,000 | 103.7K | +8% | — |
| D | 2025-02-12 | 2025-02-10 | TVTX | ROTE WILLIAM E. | SVP, R, D | M - OptEx | $0.00 | -8,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-12 | S | D | 5,200 | $23.53 | 98,519 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-10 | M | A | 8,000 | — | 103,719 | D | — | — | (F2) Each PSU represents a contingent right to receive one share of the common stock of the Issuer. |
| 3 | Derivative | Performance-based restricted stock units | 2025-02-10 | M | D | 8,000 | $0.00 | 0 | D | — · — to — | 8,000 Common Stock | (F2) Each PSU represents a contingent right to receive one share of the common stock of the Issuer. |